These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16565619)

  • 1. Quality of life in patients with advanced non-small cell lung cancer.
    Bozcuk H; Dalmis B; Samur M; Ozdogan M; Artac M; Savas B
    Cancer Nurs; 2006; 29(2):104-10. PubMed ID: 16565619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
    de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
    BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
    Dai YL; Yang CT; Chen KH; Tang ST
    J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).
    Visser S; de Mol M; Cheung K; van Toor JJ; van Walree NC; Stricker BH; Den Oudsten BL; Aerts JGJV
    Clin Lung Cancer; 2018 Jul; 19(4):e503-e516. PubMed ID: 29705017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
    Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
    Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
    J Clin Oncol; 2006 Aug; 24(24):3831-7. PubMed ID: 16921034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
    Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA
    J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staged versus conventional nursing for patients receiving chemotherapy for advanced non-small cell lung cancer: a before and after study.
    Zhu L; Chen L; Kan H; Cai P
    Ann Palliat Med; 2021 Jan; 10(1):250-257. PubMed ID: 33474963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.
    Blackhall F; Kim DW; Besse B; Nokihara H; Han JY; Wilner KD; Reisman A; Iyer S; Hirsh V; Shaw AT
    J Thorac Oncol; 2014 Nov; 9(11):1625-33. PubMed ID: 25436797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.
    Mu XL; Li LY; Zhang XT; Wang SL; Wang MZ
    BMC Cancer; 2004 Aug; 4():51. PubMed ID: 15318946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
    Dancey J; Shepherd FA; Gralla RJ; Kim YS
    Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer].
    Zhou SW; Ren SX; Yan LH; Zhang L; Zhou CC
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):469-72. PubMed ID: 19024526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy.
    Daroszewski C; Stasiewicz M; Jaźwińska-Tarnawska E; Rachwalik A; Mura E; Luboch-Kowal J; Dryś A; Bogucki ZA; Brzecka A
    Adv Exp Med Biol; 2019; 1160():11-18. PubMed ID: 30825114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gefitinib in the treatment of advanced non-small-cell lung cancer].
    Zhang L; Yu SY
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):539-41. PubMed ID: 17147123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.